基于E7抗原与IL-12细胞因子的mRNA疗法在头颈癌小鼠模型中的有效治疗
研究在模拟人乳头瘤病毒相关头颈癌的mEER荷瘤小鼠中评估编码HPV16 E7、IL-12和GM-CSF的mRNA疫苗的抗肿瘤与抗转移效果。E7与IL-12 mRNA联合免疫使肿瘤大小显著缩小且与肿瘤大小无关,肿瘤细胞MHC1表达显著增加,再植入mEER细胞后无肿瘤发生。局部递送IL-12未显示毒性证据或T细胞耗竭标志物减少,并诱导肺组织E7特异性记忆T细胞。
要点
- E7与IL-12 mRNA联合免疫使mEER荷瘤小鼠肿瘤大小显著缩小,且与肿瘤大小无关。
- 联合免疫后肿瘤细胞MHC1表达显著增加,再植入mEER细胞后无肿瘤发生。
- 局部mRNA递送IL-12未显示毒性证据或T细胞耗竭标志物减少,并诱导肺组织E7特异性记忆T细胞。
核心结论
- E7与IL-12 mRNA联合免疫是HPV阳性头颈癌患者的高效治疗选择,并可能适用于其他癌症。
研究设计与样本
- 研究将培养的mEER细胞注射入C57BL/6小鼠,并用编码HPV16 E7、GM-CSF和IL-12的mRNA-LNP进行免疫。
- 监测肿瘤生长,并用流式细胞术和酶联免疫斑点试验分析免疫应答。
主要发现
- 用E7和IL-12 mRNA联合免疫时,无论肿瘤大小,肿瘤大小均显著缩小。
- 联合免疫后肿瘤细胞MHC1表达显著增加。
- 再植入mEER细胞后无肿瘤发生。
- 通过mRNA递送实现IL-12局部表达,未显示毒性证据或T细胞耗竭标志物减少。
- mIL-12与mE7免疫在肺组织中诱导E7特异性记忆T细胞,提示对潜在转移和复发的防御。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The incidence of head and neck cancer (HNC) caused by human papillomavirus (HPV) has increased over the past several years. The mEER murine model mimicking HNC showed relatively low efficacy following E6 and E7 immunotherapy. Therefore, this study aimed to examine the anti-tumor and anti-metastatic effects of mRNA vaccines encoding HPV 16 E7, Interleukin-12 (IL-12), and Granulocyte-Macrophage colony-stimulating factor (GM-CSF) in mEER tumor-bearing mice. C57BL/6 mice were injected with cultured mEER cells and immunized with mRNA-LNPs encoding HPV16 E7, GM-CSF, and IL-12. Tumor growth was monitored, and immune responses were analyzed using flow cytometry and Enzyme-Linked ImmunoSpot assays. When immunized with both E7 and IL-12 mRNA, the tumor size dramatically decreased regardless of tumor size, while the expression of MHC1 on tumor cells increased significantly. No tumors developed upon mEER cell re-implantation. Local expression of IL-12 via mRNA delivery revealed no evidence of toxicity or reduced T-cell exhaustion markers. Furthermore, mIL-12 immunization with mE7 induces E7-specific memory T cells in lung tissues, suggesting a defense against potential metastasis and recurrence. Immunization with E7 and IL-12 mRNA is a highly effective treatment option for patients with HPV-positive HNC and is potentially applicable to other cancers.
引用
- Lee S, Lee J, Lee YS, et al. Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice models. Vaccine. 2025. PMID: 40987001. doi:10.1016/j.vaccine.2025.127766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。